Related Experiment Video
Updated: Feb 14, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis
Linan Zeng1,2, Jinhui Tian3,4, Fujian Song5
1Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.
Insights
Dexamethasone effectively prevents bronchopulmonary dysplasia (BPD) in preterm infants. Aggressive early use is beneficial, but high-dose, long-term administration may pose neurodevelopmental risks.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Pharmacology
Background:
- Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
- Corticosteroids are used to prevent BPD, but their comparative efficacy and safety profiles require clarification.
Purpose of the Study:
- To compare the efficacy and safety of various corticosteroids for BPD prevention in preterm neonates.
- To identify optimal corticosteroid regimens for reducing BPD incidence.
Main Methods:
- Systematic literature search of PubMed, EMBASE, and Cochrane Library.
- Inclusion of 47 randomized controlled trials (RCTs) involving 6747 preterm infants.
- Bayesian network meta-analysis and subgroup analyses to assess treatment effects.
Main Results:
- Dexamethasone, both high- and low-dose, significantly reduced the risk of BPD.
- High-dose dexamethasone demonstrated superior efficacy compared to hydrocortisone, beclomethasone, and low-dose dexamethasone.
- Early and long-term dexamethasone use decreased BPD risk, but high-dose, long-term regimens were associated with potential adverse neurodevelopmental outcomes (cerebral palsy).
- Budesonide showed promise in extremely preterm infants.
Conclusions:
- Dexamethasone is effective in preventing BPD in preterm infants.
- Aggressive early initiation of dexamethasone appears beneficial.
- Avoid high-dose, long-term dexamethasone due to potential neurodevelopmental risks.
- Further large-scale RCTs with long-term follow-up are needed for dexamethasone and inhaled corticosteroids.
Objective:
To determine the comparative efficacy and safety of corticosteroids in the prevention of bronchopulmonary dysplasia (BPD) in preterm infants.
Study Design:
We systematically searched PubMed, EMBASE and the Cochrane Library. Two reviewers independently selected randomised controlled trials (RCTs) of postnatal corticosteroids in preterm infants. A Bayesian network meta-analysis and subgroup analyses were performed.
Results:
We included 47 RCTs with 6747 participants. The use of dexamethasone at either high dose or low dose decreased the risk of BPD (OR 0.29, 95% credible interval (CrI) 0.14 to 0.52; OR 0.58, 95% CrI 0.39 to 0.76, respectively). High-dose dexamethasone was more effective than hydrocortisone, beclomethasone and low-dose dexamethasone. Early and long-term dexamethasone at either high dose or low dose decreased the risk of BPD (OR 0.11, 95% CrI 0.02 to 0.4; OR 0.37, 95% CrI 0.16 to 0.67, respectively). There were no statistically significant differences in the risk of cerebral palsy (CP) between different corticosteroids. However, high-dose and long-term dexamethasone ranked lower than placebo and other regimens in terms of CP. Subgroup analyses indicated budesonide was associated with a decreased risk of BPD in extremely preterm and extremely low birthweight infants (OR 0.60, 95% CrI 0.36 to 0.93).
Conclusions:
Dexamethasone can reduce the risk of BPD in preterm infants. Of the different dexamethasone regimens, aggressive initiation seems beneficial, while a combination of high-dose and long-term use should be avoided because of the possible adverse neurodevelopmental outcome. Dexamethasone and inhaled corticosteroids need to be further evaluated in large-scale RCTs with long-term follow-ups.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Directing Effect of Substituents: meta-Directing Groups
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
Cancer Prevention
Some...

